I understand that, but it's also my understanding that the department suggested that this drug be allowed and the minister said no to it.
There is one other thing I wanted to ask, and it's to CIHR. You're reforming your funding and grant review programs. The new foundation scheme is going to give you a new set of two existing grant cycles. It would mean that there would be two applications and three distinct review stages. In 2015 and 2016, between the ending of the old cycle and the new cycle, there's a three-month shortfall in which many people who are doing the research and the granting cannot have the money to hire and keep their staff.
How are you going to address that particular and specific problem, a very practical problem actually?